A melanoma-specific peptide vaccine trial showed high levels of T-bet expression in vaccine-induced CD8+ CTL, indicating that T-bet expression may be associated with CTL tumor infiltration and anti-tumor activities [52]. Here, CD8A is linked to melanoma.